Literature DB >> 2509459

Deformylation of 32-oxo-24,25-dihydrolanosterol by the purified cytochrome P-45014DM (lanosterol 14 alpha-demethylase) from yeast evidence confirming the intermediate step of lanosterol 14 alpha-demethylation.

Y Aoyama1, Y Yoshida, Y Sonoda, Y Sato.   

Abstract

32-Oxo-24,25-dihydrolanosterol (32-oxo-DHL) was deformylated to 4,4-dimethylcholesta-8,14-dien-3 beta-ol, the product of 14 alpha-demethylation of 24,25-dihydro-lanosterol (DHL), by the reconstituted lanosterol 14 alpha-demethylase system consisting of cytochrome P-45014DM and NADPH-cytochrome P-450 reductase of yeast. Affinity of 32-oxo-DHL to the cytochrome was considerably higher than those of lanosterol and DHL, and the rate of deformylation of 32-oxo-DHL was faster than the rate of demethylation of lanosterol and DHL. Spectral analysis of the 32-oxo-DHL complex of cytochrome P-45014DM suggested the interaction between the 32-aldehyde group and the heme iron. These observations, together with our preceding findings on the metabolism of 32-hydroxy-24,25-dihydrolanosterol (Aoyama, Y., Yoshida, Y., Sonoda, Y., and Sato, Y. (1987) J. Biol. Chem. 262, 1239-1243), indicate that the 14 alpha-demethylation of lanosterol catalyzed by cytochrome P-45014DM proceeds with three step monooxygenations via the 32-hydroxy and 32-oxo intermediates, and the cytochrome mediates this sequential reaction without releasing the intermediates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509459

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors.

Authors:  L M Podust; T L Poulos; M R Waterman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding.

Authors:  Chunquan Sheng; Zhenyuan Miao; Haitao Ji; Jianzhong Yao; Wenya Wang; Xiaoying Che; Guoqiang Dong; Jiaguo Lü; Wei Guo; Wannian Zhang
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

3.  Cloning, expression, purification and spectrophotometric analysis of lanosterol 14-alpha demethylase from Leishmania braziliensis (LbCYP51).

Authors:  Humberto F Freitas; Acássia Benjamim Leal Pires; Marcelo S Castilho
Journal:  Mol Biol Rep       Date:  2018-01-23       Impact factor: 2.316

4.  Large-scale identification of yeast integral membrane protein interactions.

Authors:  John P Miller; Russell S Lo; Asa Ben-Hur; Cynthia Desmarais; Igor Stagljar; William Stafford Noble; Stanley Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-10       Impact factor: 11.205

5.  Sterol 14alpha-demethylase activity in Streptomyces coelicolor A3(2) is associated with an unusual member of the CYP51 gene family.

Authors:  David C Lamb; Kay Fowler; Tobias Kieser; Nigel Manning; Larissa M Podust; Michael R Waterman; Diane E Kelly; Steven L Kelly
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

6.  NADPH cytochrome P-450 oxidoreductase and susceptibility to ketoconazole.

Authors:  K Venkateswarlu; D E Kelly; N J Manning; S L Kelly
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

Review 7.  Drug strategies targeting CYP51 in neglected tropical diseases.

Authors:  Jun Yong Choi; Larissa M Podust; William R Roush
Journal:  Chem Rev       Date:  2014-10-22       Impact factor: 60.622

8.  CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).

Authors:  Anjan Debnath; Claudia M Calvet; Gareth Jennings; Wenxu Zhou; Alexander Aksenov; Madeline R Luth; Ruben Abagyan; W David Nes; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2017-12-28

Review 9.  Fungal Cytochrome P450s and the P450 Complement (CYPome) of Fusarium graminearum.

Authors:  Jiyoung Shin; Jung-Eun Kim; Yin-Won Lee; Hokyoung Son
Journal:  Toxins (Basel)       Date:  2018-03-07       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.